» Articles » PMID: 4323443

Experimental Respiratory Infection with Type 4 Adenovirus Vaccine in Volunteers: Clinical and Immunological Responses

Overview
Journal J Infect Dis
Date 1970 Oct 1
PMID 4323443
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.

Matsuda K, Migueles S, Huang J, Bolkhovitinov L, Stuccio S, Griesman T J Clin Invest. 2021; 131(5).

PMID: 33529172 PMC: 7919717. DOI: 10.1172/JCI140794.


Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response.

Collins N, Adhikari A, Yang Y, Kuschner R, Karasavvas N, Binn L Vaccines (Basel). 2020; 8(3).

PMID: 32718082 PMC: 7564809. DOI: 10.3390/vaccines8030411.


Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Patterson L, Robert-Guroff M Expert Opin Biol Ther. 2008; 8(9):1347-63.

PMID: 18694354 PMC: 2538611. DOI: 10.1517/14712598.8.9.1347.


Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.

Peng B, Wang L, Gomez-Roman V, Davis-Warren A, Montefiori D, Kalyanaraman V J Virol. 2005; 79(16):10200-9.

PMID: 16051813 PMC: 1182659. DOI: 10.1128/JVI.79.16.10200-10209.2005.


Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.

HARVEY B, Hackett N, El-Sawy T, Rosengart T, Hirschowitz E, Lieberman M J Virol. 1999; 73(8):6729-42.

PMID: 10400771 PMC: 112758. DOI: 10.1128/JVI.73.8.6729-6742.1999.